PATENT CLAIM ANALYSIS

Application Number: 15885333
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "232800"]

Abstract:
Disclosed herein are compounds, pharmaceutical compositions, and related methods for the treatment of viral infection, including RNA viral infection in subjects. The compounds, pharmaceutical compositions, and methods can modulate the innate immune antiviral response in vertebrate cells, including activating the RIG-I pathway.

Claim (Index 33):
The a pharmaceutical composition comprising the compound of  claim 30 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13765583', '14348516', '15419784', '13640732', '14391638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8034390993452369
- 35 USC 102 Novelty (BERT): 0.5385936412307643
- Combined Prediction Score: 0.7769545535337897
- Mean Citation Score: 353.882134
- Max Citation Score: 386.89203
- Similarity Product: 225.78939870849072

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test